Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53
暂无分享,去创建一个
Fei Zhou | Jihong Sun | Xiaoming Yang | Linbo Wang | Fang Yang | S. Xie | Jingfeng Luo | Xiufang Xu | Yanhua Zhang
[1] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[2] Andrew H. Beck,et al. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. , 2016, Cancer research.
[3] R. Schiff,et al. Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer. , 2015, Clinical breast cancer.
[4] D. Edwards,et al. Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer , 2015, Breast Cancer Research.
[5] E. Cuyás,et al. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas , 2015, Oncotarget.
[6] P. Spanheimer,et al. A Novel Animal Model for Locally Advanced Breast Cancer , 2015, Annals of Surgical Oncology.
[7] Shan Sun,et al. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain. , 2014, Cancer letters.
[8] M. Kumar,et al. Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis , 2014, Cancer Cell International.
[9] W. Han,et al. Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines. , 2013, International journal of oncology.
[10] Jun Yao,et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. , 2013, Cancer cell.
[11] Javier A Menendez,et al. Basal/HER2 breast carcinomas , 2013, Cell cycle.
[12] M. Houshmand,et al. Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines , 2012, Cancer Cell International.
[13] Yoko Takahashi,et al. Establishment and Characterization of Novel Cell Lines from Sinonasal Undifferentiated Carcinoma , 2012, Clinical Cancer Research.
[14] Dongling Yang,et al. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer , 2011, Proceedings of the National Academy of Sciences.
[15] R. Hass,et al. Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies , 2009, Journal of experimental & clinical cancer research : CR.
[16] Meijia Gu,et al. Cancer Cell International Establishment and Characterization of Three New Human Breast Cancer Cell Lines Derived from Chinese Breast Cancer Tissues , 2022 .
[17] F. Meng,et al. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers. , 2008, Human pathology.
[18] R. Ralhan,et al. Establishment and characterisation of two novel breast cancer cell lines , 2008, Cell biology international.
[19] C. Wongkham,et al. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma , 2007, Cancer.
[20] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[21] M. Olivé,et al. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.
[22] J. Yook,et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells , 2005, Experimental & Molecular Medicine.
[23] C. Osborne,et al. Biological differences among MCF-7 human breast cancer cell lines from different laboratories , 2005, Breast Cancer Research and Treatment.
[24] F. Lung,et al. p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan , 2004, Journal of Cancer Research and Clinical Oncology.
[25] J. Double,et al. Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice , 1997, Breast Cancer Research and Treatment.
[26] Valerie Speirs,et al. Breast cancer cell lines: friend or foe? , 2003, Breast Cancer Research.
[27] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[28] A. Green,et al. A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples , 1996, International journal of cancer.
[29] Robert Clarke,et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.
[30] P. Meltzer,et al. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. , 1991, British Journal of Cancer.
[31] M. Radu,et al. Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.
[32] E. L. Springer,et al. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.
[33] A. Long,et al. A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.